18 May 2013
Keywords: trial, genentech, activase, expanded, national, institutes, health
Article | 29 January 1996
A US National Institutes of Health study to assess Genentech's Activase (alteplase) in treating stroke is to be expanded following ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.